Envista Holdings Co. (NYSE:NVST – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $20.71.
A number of equities research analysts recently issued reports on NVST shares. Bank of America decreased their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and upped their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, October 31st. JPMorgan Chase & Co. downgraded Envista from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $23.00 to $16.00 in a research report on Thursday, August 8th. Finally, Robert W. Baird lifted their target price on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st.
Read Our Latest Research Report on Envista
Envista Trading Down 4.7 %
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. The business had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The company’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS. Equities research analysts anticipate that Envista will post 0.71 EPS for the current fiscal year.
Insider Transactions at Envista
In related news, CFO Eric D. Hammes bought 24,532 shares of the company’s stock in a transaction on Monday, August 12th. The shares were acquired at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the purchase, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.30% of the company’s stock.
Institutional Investors Weigh In On Envista
Several hedge funds have recently made changes to their positions in the company. GSA Capital Partners LLP lifted its position in shares of Envista by 74.7% in the 1st quarter. GSA Capital Partners LLP now owns 27,548 shares of the company’s stock worth $589,000 after purchasing an additional 11,782 shares during the period. SG Americas Securities LLC lifted its holdings in Envista by 3,271.2% during the first quarter. SG Americas Securities LLC now owns 144,522 shares of the company’s stock worth $3,090,000 after buying an additional 140,235 shares during the period. Swiss National Bank boosted its position in Envista by 4.9% during the 1st quarter. Swiss National Bank now owns 338,500 shares of the company’s stock valued at $7,237,000 after acquiring an additional 15,700 shares in the last quarter. Fiduciary Family Office LLC purchased a new position in shares of Envista in the 1st quarter valued at $223,000. Finally, William Blair Investment Management LLC raised its position in shares of Envista by 4.0% in the 1st quarter. William Blair Investment Management LLC now owns 14,049 shares of the company’s stock worth $300,000 after acquiring an additional 538 shares in the last quarter.
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- Stock Market Sectors: What Are They and How Many Are There?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- About the Markup Calculator
- MarketBeat Week in Review – 11/4 – 11/8
- 3 Healthcare Dividend Stocks to Buy
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.